abstract |
This invention relates to compounds having the formula (I). These compounds have an affinity for bradykinin receptors with selectivity for receptors, and they can be used to prepare drugs that are intended for the treatment or prevention of persistent or chronic inflammatory diseases and inflammatory pathologies. |